Adar1 Capital Management, LLC Inozyme Pharma, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 87,799 shares of INZY stock, worth $347,684. This represents 0.01% of its overall portfolio holdings.
Number of Shares
87,799
Previous 76,299
15.07%
Holding current value
$347,684
Previous $211 Million
62.2%
% of portfolio
0.01%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding INZY
# of Institutions
96Shares Held
45.9MCall Options Held
13.8KPut Options Held
1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$20.4 Million0.01% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$17.8 Million5.72% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$17 Million0.29% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.87MShares$15.3 Million0.39% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.45MShares$13.6 Million0.19% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $159M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...